{"id":441925,"date":"2021-02-23T08:48:16","date_gmt":"2021-02-23T13:48:16","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=441925"},"modified":"2021-02-23T08:48:16","modified_gmt":"2021-02-23T13:48:16","slug":"xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\/","title":{"rendered":"Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2020 Financial Results"},"content":{"rendered":"<h2>\nXenon to Participate in Fireside Discussion at SVB Leerink 10th Annual  Global Healthcare Conference<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"justify\">BURNABY, British Columbia, Feb.  23, 2021  (GLOBE NEWSWIRE) &#8212; Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced it will report its 2020 financial and operating results after the close of U.S. financial markets on Monday, March 1, 2021:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">Xenon management will host a conference call and live audio webcast at 4:30 pm Eastern Time (1:30 pm Pacific Time) on Monday, March 1, 2021 to discuss the year-end results and to provide a corporate update. The webcast will be broadcast live on the <a href=\"https:\/\/investor.xenon-pharma.com\/events-and-presentations\/upcoming-events\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Investors section<\/a> of the Xenon website. To participate in the call, please dial (855) 779-9075, or (631) 485-4866 for international callers, and provide conference ID number 6061326.<\/li>\n<\/ul>\n<p align=\"justify\">In addition, Xenon will participate in a fireside discussion at the following upcoming virtual investor conference, which will be webcast live on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Xtq6a-lpOJ5f4gD4n213iW3Izg1UJ2yaKKHEmMhrDWo0vhbeqosgdEaluo-lDtMw3w00My3A3R4VJOjNyypj4kYY3cHUZMS6MsejUaQyGhCaWp836hXApsx5Wh0Zb6dC7TwsbxaW_UlONQFVWSZw7FjdZNQWpPrjvV5HbBs5ARs=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Investors section<\/a> of the Xenon website:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">SVB Leerink 10th Annual Global Healthcare Conference at 10:00 am Eastern Time on Wednesday, February 24, 2021.<\/li>\n<\/ul>\n<p align=\"justify\">The above listed dates and times are subject to change. Details on company presentations and webcasts can be found on the \u201cInvestors\u201d section of Xenon&#8217;s website at www.xenon-pharma.com. When available, webcasts will be posted for replay following the event.<\/p>\n<p>\n        <strong><br \/>\n          <u>About Xenon Pharmaceuticals Inc.<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p>We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HSgIoeo3V3HnlkHpRCFFFD9vtfAYdIdK4oiA56MEucP06SxtW9KljwwwDnSLkrjIAN7AguR2XfT9IdaogLK_xNwMQPOWaeZXmU6JFuJTEx8=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.xenon-pharma.com<\/a>.<\/p>\n<p align=\"justify\">\u201cXenon\u201d and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.<\/p>\n<p>\n        <strong>Investor\/Media Contact<\/strong>:<br \/>Jodi Regts<br \/>Xenon Pharmaceuticals Inc.<br \/>Phone: 604.484.3353<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ibtj05IdIvXC1gnHFoEFRMsGa094E2PCNHMuN4hFkV5SucGGLzCcy6j-xew9pvA01lXirGZsuvl3k2-LX4kUQyZREAbDJd0cjH0idY9FEU6SjcZRP_CDndxyTLJgBQVB\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">investors@xenon-pharma.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzcwNCMzOTg5OTE5IzIwMTEzODA=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/bad4ece4-39dc-4738-a29a-c40b5bb78b97\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Xenon to Participate in Fireside Discussion at SVB Leerink 10th Annual Global Healthcare Conference BURNABY, British Columbia, Feb. 23, 2021 (GLOBE NEWSWIRE) &#8212; Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced it will report its 2020 financial and operating results after the close of U.S. financial markets on Monday, March 1, 2021: Xenon management will host a conference call and live audio webcast at 4:30 pm Eastern Time (1:30 pm Pacific Time) on Monday, March 1, 2021 to discuss the year-end results and to provide a corporate update. The webcast will be broadcast live on the Investors section of the Xenon website. To participate in the call, please dial (855) 779-9075, or (631) 485-4866 for international callers, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2020 Financial Results&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-441925","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2020 Financial Results - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2020 Financial Results - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Xenon to Participate in Fireside Discussion at SVB Leerink 10th Annual Global Healthcare Conference BURNABY, British Columbia, Feb. 23, 2021 (GLOBE NEWSWIRE) &#8212; Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced it will report its 2020 financial and operating results after the close of U.S. financial markets on Monday, March 1, 2021: Xenon management will host a conference call and live audio webcast at 4:30 pm Eastern Time (1:30 pm Pacific Time) on Monday, March 1, 2021 to discuss the year-end results and to provide a corporate update. The webcast will be broadcast live on the Investors section of the Xenon website. To participate in the call, please dial (855) 779-9075, or (631) 485-4866 for international callers, &hellip; Continue reading &quot;Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2020 Financial Results&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-23T13:48:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzcwNCMzOTg5OTE5IzIwMTEzODA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2020 Financial Results\",\"datePublished\":\"2021-02-23T13:48:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\\\/\"},\"wordCount\":305,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NzcwNCMzOTg5OTE5IzIwMTEzODA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\\\/\",\"name\":\"Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2020 Financial Results - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NzcwNCMzOTg5OTE5IzIwMTEzODA=\",\"datePublished\":\"2021-02-23T13:48:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NzcwNCMzOTg5OTE5IzIwMTEzODA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NzcwNCMzOTg5OTE5IzIwMTEzODA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2020 Financial Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2020 Financial Results - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\/","og_locale":"en_US","og_type":"article","og_title":"Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2020 Financial Results - Market Newsdesk","og_description":"Xenon to Participate in Fireside Discussion at SVB Leerink 10th Annual Global Healthcare Conference BURNABY, British Columbia, Feb. 23, 2021 (GLOBE NEWSWIRE) &#8212; Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced it will report its 2020 financial and operating results after the close of U.S. financial markets on Monday, March 1, 2021: Xenon management will host a conference call and live audio webcast at 4:30 pm Eastern Time (1:30 pm Pacific Time) on Monday, March 1, 2021 to discuss the year-end results and to provide a corporate update. The webcast will be broadcast live on the Investors section of the Xenon website. To participate in the call, please dial (855) 779-9075, or (631) 485-4866 for international callers, &hellip; Continue reading \"Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2020 Financial Results\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\/","og_site_name":"Market Newsdesk","article_published_time":"2021-02-23T13:48:16+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzcwNCMzOTg5OTE5IzIwMTEzODA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2020 Financial Results","datePublished":"2021-02-23T13:48:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\/"},"wordCount":305,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzcwNCMzOTg5OTE5IzIwMTEzODA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\/","name":"Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2020 Financial Results - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzcwNCMzOTg5OTE5IzIwMTEzODA=","datePublished":"2021-02-23T13:48:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzcwNCMzOTg5OTE5IzIwMTEzODA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzcwNCMzOTg5OTE5IzIwMTEzODA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2020 Financial Results"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/441925","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=441925"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/441925\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=441925"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=441925"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=441925"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}